Strategic Capital Advisers’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $4.61M | Buy |
14,214
+155
| +1% | +$50.3K | 3.81% | 4 |
|
|
2022
Q1 | $4.03M | Sell |
14,059
-646
| -4% | -$185K | 3.07% | 8 |
|
|
2021
Q4 | $4.06M | Buy |
14,705
+26
| +0.2% | +$7.18K | 2.91% | 10 |
|
|
2021
Q3 | $3.39M | Buy |
14,679
+1,085
| +8% | +$251K | 2.64% | 11 |
|
|
2021
Q2 | $3.12M | Sell |
13,594
-1,009
| -7% | -$232K | 2.58% | 15 |
|
|
2021
Q1 | $2.73M | Sell |
14,603
-3,204
| -18% | -$599K | 2.37% | 18 |
|
|
2020
Q4 | $3.01M | Sell |
17,807
-99
| -0.6% | -$16.7K | 2.56% | 16 |
|
|
2020
Q3 | $2.65M | Buy |
17,906
+226
| +1% | +$33.5K | 2.49% | 18 |
|
|
2020
Q2 | $2.9M | Sell |
17,680
-1,456
| -8% | -$239K | 2.92% | 12 |
|
|
2020
Q1 | $2.65M | Sell |
19,136
-115
| -0.6% | -$16K | 3.21% | 7 |
|
|
2019
Q4 | $2.53M | Buy |
19,251
+72
| +0.4% | +$9.46K | 2.37% | 17 |
|
|
2019
Q3 | $2.15M | Sell |
19,179
-534
| -3% | -$59.7K | 2.39% | 20 |
|
|
2019
Q2 | $2.18M | Buy |
19,713
+11,713
| +146% | +$1.3M | 2.3% | 20 |
|
|
2019
Q1 | $1.04M | Sell |
8,000
-15,805
| -66% | -$2.05M | 1.12% | 35 |
|
|
2018
Q4 | $2.75M | Sell |
23,805
-10,969
| -32% | -$1.27M | 2.96% | 8 |
|
|
2018
Q3 | $3.73M | Buy |
34,774
+81
| +0.2% | +$8.69K | 2.66% | 12 |
|
|
2018
Q2 | $3.36M | Buy |
34,693
+10,762
| +45% | +$1.04M | 2.45% | 15 |
|
|
2018
Q1 | $2.02M | Hold |
23,931
| – | – | 1.99% | 20 |
|
|
2017
Q4 | $2.02M | Buy |
+23,931
| New | +$2.02M | 1.99% | 20 |
|